Chiesi partners with Haisco to commercialise bronchiectasis drug – Pharmaceutical Technology
Share this article The collaboration will develop the HSK31858 candidate to treat respiratory diseases. Credit: mi-viri via Getty Images. Chiesi Group and Haisco Pharmaceutical have